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Abstract 
Intravascular papillary endothelial hyperplasia (IPEH), or Masson’s tumor, a rare benign 
vascular lesion, occurs mainly in the head, neck, and hands in the human population. 
Aberrant tumor locations have been rarely reported. We present a case of a patient with 
chronic abdominal pain and melena of variable severity due to a Masson’s tumor, with 
no apparent Masson’s tumor-associated comorbidities, along with a comprehensive 
review of the literature. Using PubMed, a search engine provided by the U.S. National 
Library of Medicine and the National Institutes of Health, we searched for all reports of 
Masson’s tumor limited within the abdominal cavity. Furthermore, keywords such as 
‘intravascular papillary endothelial hyperplasia’, ‘renal’, ‘gastrointestinal’, ‘hepatic’ and 
‘intraabdominal’ were used to facilitate the search. We thus found fourteen cases of 
intraabdominal Masson’s tumors published. Six (42.9%) of these were located in the renal 
vein, 4 (28.6%) were reported in the gastrointestinal tract, 1 (7.1%) in the adrenal gland, 
1 (7.1%) in the liver, and 1 (7.1%) instance with multiple lesion sites including the renal 
hilum and retroperitoneum. Among these patients, 9 (64.3%) were female and 5 (35.7%) 
male, with a mean age of 38.9 years (7–69). IPEH is a reactive process, having three 
subtypes, all involving the proliferation of epithelial cells around a thrombus in the 
setting of venous stasis. In its pure form, the organized thrombus is solely localized 
within the vascular lumen. Mixed-form IPEH is formed in preexisting vascular lesions 
(such as arteriovenous malformation, hemangioma, pyogenic granuloma, etc.). The rarest  
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form is the extravascular variety, which arises in hematomas often from recent trauma to 
the area. In its pure form, IPEH has a zero recurrence rate when an R0 resection is 
performed; all mixed and extravascular forms show the highest recurrence rates. The 
exact histogenesis of these epithelial cells remains a mystery and multiple theories have 
been offered. Although difficult to distinguish from malignant angiosarcomas solely on 
presentation and radiologic work-up, Masson’s tumors occur more frequently in women, 
demonstrate no local invasion, do not metastasize, are commonly located 
intravascularly, and are associated with a significantly more favorable prognosis than 
angiosarcomas. Only four Masson’s tumors have been reported in the gastrointestinal 
tract, two of these cases were related to microvascular thrombosis secondary to 
paroxysmal nocturnal hemoglobinuria and two were formed secondary to arteriovenous 
malformations. Our case lacked solitary evidence of either of these comorbidities. An 
incidental finding of an enlarged ovary, which was removed during our exploratory 
laparoscopy, plus strong demographic statistics that suggest women have an increased 
prevalence of this lesion may help support a hormonal theory of pathogenesis. 
Introduction 
Intravascular papillary endothelial hyperplasia (IPEH), or Masson’s tumor, is a benign 
reactive process whereby endothelial cells organize around fragmented thrombi in the 
presence of venous stasis [1–3]. This benign tumor has been well described, affecting 
blood vessels of the head, neck, and fingers. Less frequently, IPEH has been documented 
in the upper respiratory tract, skeletal muscle, urogenital systems, renal and hepatic 
systems, and rarely in the gastrointestinal tract. To date, 14 cases of IPEH arising within 
the abdominal cavity have been reported [4–16], and only 4 cases involved the 
gastrointestinal tract [13–16]. In each of the 4 cases in which IPEH involved the 
gastrointestinal tract, a primary pathologic etiology was elucidated. We present a novel 
case of IPEH presenting as a gastrointestinal hemorrhage without any discoverable cause. 
A comprehensive discussion of the clinical presentation, management, and prognosis of 
these rare tumors is provided. 
Case Report 
A 50-year-old female presented with a history of intermittent abdominal pain, black tarry stools and 
anemia of variable severity over the prior 1.5 years. Her medical history was only significant for 
hypertension. Surgical history was remarkable for a tubal ligation, exploratory laparotomy for a 
ruptured ectopic pregnancy and a cesarean section. She denied fever, vomiting or weight loss. 
Cardiovascular and respiratory systems exhibited no abnormalities on physical examination and there 
was no evidence of hepatomegaly or splenomegaly. 
At the initial onset of symptoms she was treated with H2 blockers and subsequent upper endoscopy 
showed only mild gastritis. Upon recurrence of black tarry stools, a colonoscopy and capsule endoscopy 
were performed and revealed no cause of bleeding. She subsequently underwent a balloon enteroscopy 
which revealed a hemmorhagic lesion within the proximal small bowel, which was marked with Indian 
ink to facilitate location during a planned laparoscopic resection. Preoperative computed tomography of 
the abdomen revealed a large left ovarian cyst with complex architecture and the patient elected to 
undergo total abdominal hysterectomy with a bilateral salpingo-oophorectomy concurrent with the 
planned bowel resection. 
At surgery, the area of Indian ink was located 45 cm distally to the ligament of Treitz. The 
surrounding mesentery revealed multiple nodular-like fibrotic areas from the ligament of Treitz to the 
lesion. Frozen sectioning of the mesentery revealed nonspecific fibroblastic proliferation and reactive 
mesothelial cells. A 20 cm segment of jejunum was resected, and a primary anastomosis was performed.  
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The patient recovered uneventfully and at seven-month follow-up she remains well without recurrent 
bleeding. 
On gross examination, the small bowel mucosa revealed a polypoid tan-grey lesion measuring 0.4 × 
0.4 × 0.2 cm with a pinpoint ulceration located 4 cm from the inked area (fig. 1). Microscopically, the 
polypoid lesion was a 0.4 × 0.4 cm well-circumscribed endothelial proliferation located within the 
submucosa (fig. 2). The lesion was confined to the vascular lumen and consisted of a complex network 
of vascular channels, papillary structures and an organizing thrombus. The papillae consisted of a 
central fibroconnective core and a surrounding attenuated single layer of endothelium. There was no 
necrosis, pleomorphism, or atypical mitoses present. Immunochemical staining for Factor VIII and 
CD34 (markers of endothelial cells) were positive in the cells lining the papillae (fig. 3a, b). 
Histochemical staining for elastin demonstrated a circumferential elastic lamina of the vessel (fig. 3c), 
and a pathologic diagnosis of IPEH was made. 
Discussion 
IPEH was first described by Pierre Masson in 1923 [17]. This sentinel paper involved a 
68-year-old male with a thrombosed hemorrhoidal vein. IPEH was initially termed a 
‘hémangioendothéliome végétant intravasculaire’ [3]. Nine years later, Henschen [18] 
described this proliferation as a reactive process rather than a true neoplasm and named 
the lesion ‘endovasculite proliférante thrombopoïétique’. In 1976, Clearkin and Enzinger 
[2] coined the current name ‘intravascular papillary endothelial hyperplasia’, which has 
gained wide acceptance as the best description of this lesion. 
The precise pathogenesis of IPEH lesions remains elusive. In 1923, Masson [17] 
proposed that the lesion represented a true neoplasm with secondary thrombosis. 
However, other authors have demonstrated that the growth pattern of IPEH suggest a 
benign reactive process consisting of endothelial cells organizing and proliferating around 
a thrombosis in the setting of venous stasis [1–3]. On a cellular level, IPEH closely 
resembles granulation tissue, which further supports the theory that this process is 
reparative [19]. The endothelial cells appear to originate, in its earliest formation, with a 
histiocytic phenotype before transformation to an endothelial phenotype [20], further 
lending support to a reactive theory. 
In 1983, Hashimoto et al. [1] described three distinct types of IPEH, and in 1993 Pins 
et al. [21] calculated the incidence of each type after a comprehensive literature review. 
The ‘pure’ form (55.8%) arises de novo in a dilated vascular space with no causative 
comorbidity. The ‘mixed’ form (39.9%) is found superimposed over a preexisting vascular 
anomaly. Such associated anomalies may include arteriovenous malformations, 
hemangiomas, pyogenic granulomatosis, and chronic illnesses such as paroxysmal 
nocturnal hemoglobinuria, which is associated with venous thrombosis [13, 14]. The 
‘extravascular’ form (4.3%) is associated primarily with trauma-induced hematoma 
formation, which acts as a template for endothelial proliferation.  
To date, only 15 cases of intraabdominal Masson’s tumors have been reported, 
including the current case (table 1). Six cases (40.0%) were located in the renal vein [4–8], 
five (33.3%) were reported in the gastrointestinal tract [13–16], two (13.3%) in the adrenal 
gland [10, 11], and one (6.7%) in the liver [12]. An additional case (6.7%) involved 
multiple lesions located in the renal hilum and the retroperitoneum [9]. Among these 
patients, 10 (66.7%) were female and 5 (33.3%) male, with a mean age of 38.9 years 
(range 7–69). Among the five cases of IPEH involving the gastrointestinal tract (including 
the current case), three (60%) were located in the jejunum, one (20%) was located in both 
the distal duodenum and proximal jejunum, and once case (20%) occurred at the ileocecal 
valve. In the previously published four cases of IPEH involving the gastrointestinal tract, a  
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preexisting diagnosis of paroxysmal nocturnal hemoglobinuria was believed to be the 
attributable cause of microvascular thrombi in both the ileocecal and duodenal/jejunal 
cases [13, 14], and the two cases of jejunal IPEH (prior to this case) attributed to 
arteriovenous malformations [15, 16]. All four previous reports of the IPEH involving the 
gastrointestinal tract were a ‘mixed’ form lesion. The current case of jejunal IPEH 
represents the first report of a ‘pure’ form IPEH involving the gastrointestinal tract and 
presents a novel cause of hemorrhage which the clinician should be aware of. 
IPEH are very rare lesions, making diagnosis difficult, and confusion with other 
clinical entities such as angiosarcoma is common [21, 22]. Given that confusion with 
angiosarcomas occurs primarily because of the unique factors of IPEH, which include 
their ability to outgrow the confines of the vascular lumen and rupture the vessel similarly 
to an invasive angiosarcoma, evaluation by an expert surgical pathologist or referral 
center should be done if there is any doubt and prior to beginning antineoplastic therapy. 
There are no definitive or specific radiographic appearances for IPEH. Computed 
tomography, magnetic resonance imaging, and angiographic patterns of IPEH can mimic 
other benign and malignant processes such as pyogenic granuloma, Kaposi’s sarcoma, 
hemangioma, bacillary angiomatosis, and papular angioplasia [9, 22]. 
Demographically, females appear slightly more susceptible to IPEH than males (1.2:1) 
[1], with an no age predilection (range 7 months to 81 years) [1, 21]. Irey and Norris [23] 
have suggested that a hormonal factor may be operational in the slight female prevalence 
to IPEH, however this has not been further substantiated. In the current case, the 
epithelial cells of the IPEH were ER–/PR–. 
Surgical resection is curative for IPEH in its pure form and no recurrence of 
Masson’s tumor has been reported after surgical resection with clear margins. Recurrence 
rates in various skin cases have been documented in a range of 7–10% for mixed and 
extravascular varieties [1, 2, 22, 24]. 
Conclusion 
IPEH is a very rare lesion that most commonly involves the head, neck and fingers. 
IPEH rarely arises within the abdominal cavity and typically presents with pain, anemia 
and bleeding. Surgery remains the only treatment for IPEH and is associated with an 
excellent prognosis and a low recurrence rate. Females demonstrate a slight prevalence of 
IPEH, but hormonal theories for the pathogenesis of IPEH remain unsubstantiated. More 
aggressive lesions such as angiosarcoma should be excluded when considering the 
histologic diagnoses of IPEH, and expert pathologic review is vital. A thorough work-up 
to exclude associated systemic illnesses is important when a ‘pure’ form of IPEH is 
diagnosed. This report represents the first ‘pure’ form of an IPEH within the 
gastrointestinal tract and represents a novel cause of gastrointestinal bleeding which the 
clinician should consider when evaluating a patient with atypical or difficult 
gastrointestinal bleeding sources. 
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Table 1. All reported cases of intraabdominal IPEH by location 
Case Reference  Location  Age Sex  Presenting  symptoms  Tumor 
type 
Causative 
comorbidity 
Treatment 
01 Garber  et  al., 
1990 [4] 
right renal vein  57  M  gross hematuria  pure    nephrectomy 
02 Steffe  and   
Iskandar, 
1996 [5] 
renal allograft  63  F  nausea, vomiting, 
diarrhea, abrupt  
decline in urine output
mixed arteriovenous 
malformation 
transplant 
nephrectomy 
03  Johraku et al., 
1997 [6] 
right renal vein  55  F  incidental finding  mixed  N/A  resection of the 
mass, sparing the 
kidney 
04  Kim et al., 
2000 [7] 
left renal vein  7  F  intermittent  
abdominal pain, 
gross hematuria 
mixed N/A  nephrectomy 
05 Akhtar  et  al., 
2005 [8] 
left renal vein  40  M  intermittent left loin 
pain with gross  
hematuria 
N/A N/A  nephrectomy 
06 Akhtar  et  al., 
2005 [8] 
left renal vein  48  M  incidental finding  N/A  N/A  nephrectomy 
07  Petry et al., 
2009 [9] 
right renal hilum, 
retroperitoneum 
and spine 
47 M persistent  low  back 
pain  
mixed Wegener 
granulmatosis 
nephrectomy  
08  Gaffey et al., 
1989 [10] 
adrenal   49  F  hematuria  pure    adrenalectomy 
09 Kawashima   
et al., 1986 [11] 
adrenal 60  F  occasional  back   
pain 
pure   adrenalectomy 
10  Hong et al., 
2004 [12] 
left hepatic lobe  69  F  myalgia, fever, chill, 
epigastric pain 
N/A   left  hemihepa-
tectomy with 
surrounding 
lymphadenectomy
11  Gartner et al., 
1988 [13] 
ileocecal valve   13  F  right lower  
abdominal pain 
mixed paroxysmal 
nocturnal 
hemoglobinuria 
resection 
12  Dunphy et al., 
1994 [14] 
distal duodenum 
and proximal 
jejunum 
17 M malaise,  abdominal 
pain, nausea, vomiting, 
anorexia, weight loss, 
jaundice, hematuria, 
anemia 
mixed paroxysmal 
nocturnal 
hemoglobinuria 
resection 
13  Okauchi et al., 
1982 [15] 
jejunum  30  F  melena, anemia  mixed  associated with 
arteriovenous 
malformation 
resection 
14  Mestiri et al., 
2007 [16] 
jejunum  20  F  melena, anemia  mixed  associated with 
arteriovenous 
malformation 
resection 
15  Current study  jejunum  50  F  melena, anemia  pure    resection 
N/A =  Not available. 
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Fig. 1. Macroscopic imaging: A polypoid tan-grey lesion on the mucosa of the small bowel with focal 
ulceration. 
 
 
 
Fig. 2. The lesion was composed primarily of a complex network of vascular channels, papillary 
structures and an organizing thrombus confined to the vascular lumen. H&E, 40×. 
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Fig. 3. Histological staining for Factor VIII, CD34 and elastin, 40×. Factor VIII (a) and CD34 (b) 
stains in endothelial cells were positive and an elastic stain highlighted a circumferential elastic 
lamina (c). 
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